Analysts at Cantor Fitzgerald assumed coverage on shares of Medmen Enterprises (OTCMKTS:MMNFF) in a research report issued to clients and investors on Thursday, MarketBeat reports. The brokerage set a “neutral” rating on the stock.
A number of other brokerages have also commented on MMNFF. Cowen raised shares of Medmen Enterprises from an “underperform” rating to a “market perform” rating and set a $0.75 price objective on the stock in a research report on Tuesday, December 17th. Seaport Global Securities reissued a “buy” rating and issued a $4.00 price objective on shares of Medmen Enterprises in a research report on Monday, December 9th.
Shares of MMNFF stock opened at $0.30 on Thursday. The company’s fifty day simple moving average is $0.47 and its 200-day simple moving average is $1.11. Medmen Enterprises has a 12 month low of $0.28 and a 12 month high of $3.51.
MedMen Enterprises Inc, together with its subsidiaries, operates as a cannabis company in the United States. The company cultivates, produces, and distributes, and retails recreational and medicinal cannabis. As of November 1, 2018, it had licenses for 69 retail stores; and 17 cultivation and production facilities across 12 states.
Read More: Derivative
Receive News & Ratings for Medmen Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medmen Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.